Literature DB >> 8739095

Presence of prostaglandin EP4 receptor gene expression in a rat gastric mucosal cell line.

S Hassan1, Y Kinoshita, D Min, H Nakata, K Kishi, Y Matsushima, M Asahara, H Y Wang, A Okada, T Maekawa, H Matsui, T Chiba.   

Abstract

RGM-1 is an epithelial cell line established from gastric mucosa of adult Wistar rats. In this study, we characterized this newly established cell line by Northern blot analysis. We also investigated deoxyribonucleic acid (DNA) synthesis and hexosamine production in RGM-1 by PGE2. Northern blot analysis did not detect any transcript of proton pump, gastrin receptor, histidine decarboxylase, somatostatin and pepsinogen 1, indicating the absence of characteristics of parietal, ECL, D and chief cells in RGM-1 cells. However, this periodic acid-Schiff (PAS)-positive cell line expressed prostaglandin EP4 receptor mRNA but not EP1 and EP3 receptor mRNAs. [3H]-thymidine incorporation into DNA of the cells was not increased by PGE2. In contrast, PGE2 increased hexosamine content in RGM-1 cells. These results suggest that RGM-1 may be a useful model of gastric mucosal cells and that PGE2 plays a role on mucin synthesis in RGM-1 cells possibly via EP4 receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739095     DOI: 10.1159/000201339

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

1.  Neoplastic transformation and induction of H+,K+ -adenosine triphosphatase by N-methyl-N'-nitro-N-nitrosoguanidine in the gastric epithelial RGM-1 cell line.

Authors:  Osamu Shimokawa; Hirofumi Matsui; Yumiko Nagano; Tsuyoshi Kaneko; Takeshi Shibahara; Akira Nakahara; Ichinosuke Hyodo; Akinori Yanaka; Hideyuki J Majima; Yukio Nakamura; Yasushi Matsuzaki
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-11-22       Impact factor: 2.416

2.  Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression.

Authors:  Yuji Naito; Hirokazu Kajikawa; Katsura Mizushima; Makoto Shimozawa; Masaaki Kuroda; Kazuhiro Katada; Tomohisa Takagi; Osamu Handa; Satoshi Kokura; Hiroshi Ichikawa; Norimasa Yoshida; Hirofumi Matsui; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  Identification, regulation and anti-proliferative role of the NPR-C receptor in gastric epithelial cells.

Authors:  William R Gower; Gay M Carter; Quentin McAfee; Suzanne M Solivan
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

4.  16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors.

Authors:  Tomonori Kunikata; Akiko Tanaka; Tohru Miyazawa; Shinichi Kato; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

5.  Interleukin-1beta inhibits growth factor-stimulated restoration of wounded rat gastric epithelial cell monolayers.

Authors:  E Nakamura; S Takahashi; H Matsui; S Okabe
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

6.  Black tea and theaflavins assist healing of indomethacin-induced gastric ulceration in mice by antioxidative action.

Authors:  Biplab Adhikary; Sudhir Kumar Yadav; Kshama Roy; Sandip K Bandyopadhyay; Subrata Chattopadhyay
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-29       Impact factor: 2.629

7.  Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice.

Authors:  Debashish Banerjee; Sayanti Bhattacharya; Sandip K Bandyopadhyay; Subrata Chattopadhyay
Journal:  Dig Dis Sci       Date:  2008-04-23       Impact factor: 3.199

8.  Healing potential of Picrorhiza kurroa (Scrofulariaceae) rhizomes against indomethacin-induced gastric ulceration: a mechanistic exploration.

Authors:  Debashish Banerjee; Biswanath Maity; Subrata K Nag; Sandip K Bandyopadhyay; Subrata Chattopadhyay
Journal:  BMC Complement Altern Med       Date:  2008-01-31       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.